Tilvestamab MMAE Antibody
Tilvestamab-MMAE is an AXL-targeting antibody-drug conjugate (ADC) for research use, delivering the cytotoxic payload MMAE. It is applied in preclinical studies for acute myeloid leukemia and solid tumors, including in vitro cytotoxicity assays and in vivo xenograft models.
Product Specifications
Target
TAM Receptor
Conjugation
Unconjugated
Field of Research
Signal Transduction
Molecular Weight
150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog